Synopsis: TruAlt Bioenergy is transitioning beyond its stabilized ethanol business toward higher-growth segments like CBG and SAF. With ethanol operating at peak utilization and delivering steady cash flows, the company is investing in high-margin biogas and future aviation fuel, positioning itself as a diversified bioenergy platform driven by policy support and energy transition trends.
TruAlt Bioenergy has reached a turning point where its ethanol business, once the primary growth driver, has matured into a stable revenue base. Operating at high utilization with no further capacity expansion planned, the company is now shifting its focus toward new growth engines. Compressed Biogas (CBG) and Sustainable Aviation Fuel (SAF) have emerged as key pillars in this transition, supported by strong margins, policy tailwinds, and rising demand for cleaner fuels. This strategic pivot reflects TruAlt’s broader ambition to evolve into a multi-fuel bioenergy platform.
Ethanol Base
TruAlt Bioenergy Ltd has moved into another stage of its life cycle where the ethanol business has matured to become more of a stable income stream rather than the driver of its growth. TruAlt has completed all the targeted capital investment towards grain-based integration, and its entire ethanol capacity has been put to work. According to management, the company currently operates under a relatively stable monthly production volume of about 5.5 to 6 crore litres, with a 95% utilisation rate on working days.
The maturity of the company is important, as it means that it is at the optimal size in terms of producing ethanol. Given there will be no capacity expansion in the ethanol business in the future, it is reasonable to assume that this business line will continue to generate recurring revenue between Rs 350 crore and Rs 400 crore per month. This can form a solid foundation for TruAlt’s financial performance going forward; however, the absence of growth in this field can drive the company towards new opportunities.
Policy Support
The Indian ethanol sector has reached a significant threshold through its ability to meet the E20 blending level, indicating that both the policies and the sector are well-advanced. It is also noted from the transcript that there have been deliberations on increasing the blending level to E27, with prospects of ethanol-blended diesel, as well as using ethanol as a raw material for jet fuel production.
All of the above increase the demand horizon of ethanol, but at the same time, they signify a fundamental shift in the positioning of ethanol within the energy ecosystem. Instead of being treated only as a blending fuel, ethanol is increasingly becoming the basic ingredient in producing high-value biofuels. This is quite similar to the TruAlt strategy in that ethanol forms a building block of future energy activities.
CBG Growth
The most promising area for near-future growth for TruAlt is going to be its Compressed Biogas (CBG) product line. The company has been showing strong performance in this field with EBITDA margins at 63% and PAT margins of 43%. These figures are much higher compared to the margins in the ethanol industry, so CBG could be seen as an essential part of future earnings.
The revenue generated by this business line has also experienced strong growth, reaching Rs.30.97 crores from Rs.19.89 crores for 9 months, resulting in more than a 55% growth rate. In other words, the company managed to overcome all learning curves related to production and started scaling the business. The management has set the goal to develop this line in the coming time in order to support future earnings.
CBG Scale
TruAlt’s growth ambitions within the CBG industry involve setting a roadmap for establishing 24 greenfield projects in the next two to three years. This will be done in conjunction with Sumitomo Corporation and GAIL Ltd, utilising the combined strength of international experience and local capabilities.
The timing of implementation is well articulated, as evidenced by four plants already under construction and set to be operational by July 2026. In the coming years, TruAlt’s target is to set up plants that will help increase its production capacity. Government policy has made this segment more attractive with advantages such as exemptions in excise duties, availability of infrastructure, and incentives. A successful implementation of this strategy would see CBG turn from a minor income earner to a major source of income and profits for TruAlt.
SAF Bet
Even though CBG will support near-term growth, TruAlt’s foray into the SAF sector can be viewed as a longer-term strategic move. In order to enter this market, the firm is setting up a 100 million litre pa SAF plant in Andhra Pradesh, at an estimated CAPEX of more than Rs 2,000 crore.
The development of the plant is aided by a technology licensing deal with Honeywell UOP, and the company is looking to form partnerships in relation to equity investments in the plant. Revenue recognition from this activity will likely commence by FY28.
The reason why this business can be considered a lucrative one is the fact that SAF commands high prices, with realisations expected to range between Rs.180 and Rs.200 per litre, which is higher than those from ethanol production. At the same time, the SAF market carries greater risks.
Demand Outlook
The demand prospects for SAF over the long term seem promising owing to regulatory initiatives both internationally and domestically. From the transcript, it emerges that India plans to roll out its own blending policies whereby the percentage will begin at 1% in FY27, rise to 2% by FY28, and escalate to 5% by 2030. In some places, there is approval for blending percentages of up to 50%.
In order to safeguard against demand uncertainty, TruAlt is endeavouring to sign offtake deals with oil corporations as well as airline firms. In addition, TruAlt is considering exporting SAF to jurisdictions where there is already voluntary uptake of the fuel.
Financial Phase
The results of TruAlt are reflective of the stage that it is currently at. Total revenue for the first nine months ended in December 2025 was Rs.1,187 crore, which amounts to an increase of 13.28% from last year. EBITDA reached Rs.170.99 crore, and PAT was Rs.35.92 crore, although there was only slight growth.
Profitability has been negatively affected by higher expenses related to expansion and financing, with the added factor of depreciation expenses and partial plant utilisation having affected revenue generation. The company expects to see this problem addressed in the future as the plant starts running efficiently, leading to cash flow from investments in new plant equipment. In terms of future projections, the company is looking forward to improved performance in terms of revenue and margins, especially in the last quarter.
Platform Shift
In addition, the overall story that comes through from the transcript is the evolution of TruAlt into a multi-fuelled bioenergy platform. In addition to ethanol, CBG, and SAF, TruAlt is currently researching other future fuel technologies, including green hydrogen, green methanol, and advanced biofuels. Although these strategies are still in their initial stages, they reflect the firm’s plans to position itself within the whole energy transition value chain. Through this transformational journey, TruAlt will be able to utilise its core competencies while progressively moving into more profitable areas.
Conclusion
The journey to diversify from ethanol by TruAlt Bioenergy has begun. The firm has created a solid footing for itself in ethanol production, discovered lucrative areas in CBG, and taken a huge risk in SAF production.
While the potential of this venture is high, its success will largely be determined by implementation, especially scaling up of operations in CBG production and completion of the SAF project on schedule. In summary, the diversification of TruAlt into CBG and SAF production is not only necessary but inevitable because growth in the future will hinge on these areas.
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
The post TruAlt Bioenergy: Can the Ethanol Stock Diversify Further into CBG and SAF? appeared first on Trade Brains.